EMA Guideline on good pharmacovigilance practices (GVP) 4 Module VI – Management and reporting of adverse reactions
![Revision 2 of EU Module VI of Guidelines on Good Pharmacovigilance Practices (GVP) - PharSafer® - Specialists in Global Clinical and Post Marketing Drug Safety Revision 2 of EU Module VI of Guidelines on Good Pharmacovigilance Practices (GVP) - PharSafer® - Specialists in Global Clinical and Post Marketing Drug Safety](https://www.pharsafer.com/wp-content/uploads/2017/07/Checking-Facts-1000x563.jpg)
Revision 2 of EU Module VI of Guidelines on Good Pharmacovigilance Practices (GVP) - PharSafer® - Specialists in Global Clinical and Post Marketing Drug Safety
![Figure 1 from A NEW ERA OF DRUG SAFETY - NEW EU PHARMACOVIGILANCE (PV) LEGISLATION AND COMPARISON OF PV IN EU, US AND INDIA Review Article | Semantic Scholar Figure 1 from A NEW ERA OF DRUG SAFETY - NEW EU PHARMACOVIGILANCE (PV) LEGISLATION AND COMPARISON OF PV IN EU, US AND INDIA Review Article | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/db07227fa8520f30feea52852ac302f729242a65/2-Figure1-1.png)